<!DOCTYPE html><html><head>
      <title>cardiology</title>
      <meta charset="utf-8">
      <meta name="viewport" content="width=device-width, initial-scale=1.0">
      
      <link rel="stylesheet" href="file:///c:\Users\Newbi\.vscode-insiders\extensions\shd101wyy.markdown-preview-enhanced-0.8.10\crossnote\dependencies\katex\katex.min.css">
      
      
      
      
      
      <style>
      code[class*=language-],pre[class*=language-]{color:#333;background:0 0;font-family:Consolas,"Liberation Mono",Menlo,Courier,monospace;text-align:left;white-space:pre;word-spacing:normal;word-break:normal;word-wrap:normal;line-height:1.4;-moz-tab-size:8;-o-tab-size:8;tab-size:8;-webkit-hyphens:none;-moz-hyphens:none;-ms-hyphens:none;hyphens:none}pre[class*=language-]{padding:.8em;overflow:auto;border-radius:3px;background:#f5f5f5}:not(pre)>code[class*=language-]{padding:.1em;border-radius:.3em;white-space:normal;background:#f5f5f5}.token.blockquote,.token.comment{color:#969896}.token.cdata{color:#183691}.token.doctype,.token.macro.property,.token.punctuation,.token.variable{color:#333}.token.builtin,.token.important,.token.keyword,.token.operator,.token.rule{color:#a71d5d}.token.attr-value,.token.regex,.token.string,.token.url{color:#183691}.token.atrule,.token.boolean,.token.code,.token.command,.token.constant,.token.entity,.token.number,.token.property,.token.symbol{color:#0086b3}.token.prolog,.token.selector,.token.tag{color:#63a35c}.token.attr-name,.token.class,.token.class-name,.token.function,.token.id,.token.namespace,.token.pseudo-class,.token.pseudo-element,.token.url-reference .token.variable{color:#795da3}.token.entity{cursor:help}.token.title,.token.title .token.punctuation{font-weight:700;color:#1d3e81}.token.list{color:#ed6a43}.token.inserted{background-color:#eaffea;color:#55a532}.token.deleted{background-color:#ffecec;color:#bd2c00}.token.bold{font-weight:700}.token.italic{font-style:italic}.language-json .token.property{color:#183691}.language-markup .token.tag .token.punctuation{color:#333}.language-css .token.function,code.language-css{color:#0086b3}.language-yaml .token.atrule{color:#63a35c}code.language-yaml{color:#183691}.language-ruby .token.function{color:#333}.language-markdown .token.url{color:#795da3}.language-makefile .token.symbol{color:#795da3}.language-makefile .token.variable{color:#183691}.language-makefile .token.builtin{color:#0086b3}.language-bash .token.keyword{color:#0086b3}pre[data-line]{position:relative;padding:1em 0 1em 3em}pre[data-line] .line-highlight-wrapper{position:absolute;top:0;left:0;background-color:transparent;display:block;width:100%}pre[data-line] .line-highlight{position:absolute;left:0;right:0;padding:inherit 0;margin-top:1em;background:hsla(24,20%,50%,.08);background:linear-gradient(to right,hsla(24,20%,50%,.1) 70%,hsla(24,20%,50%,0));pointer-events:none;line-height:inherit;white-space:pre}pre[data-line] .line-highlight:before,pre[data-line] .line-highlight[data-end]:after{content:attr(data-start);position:absolute;top:.4em;left:.6em;min-width:1em;padding:0 .5em;background-color:hsla(24,20%,50%,.4);color:#f4f1ef;font:bold 65%/1.5 sans-serif;text-align:center;vertical-align:.3em;border-radius:999px;text-shadow:none;box-shadow:0 1px #fff}pre[data-line] .line-highlight[data-end]:after{content:attr(data-end);top:auto;bottom:.4em}html body{font-family:'Helvetica Neue',Helvetica,'Segoe UI',Arial,freesans,sans-serif;font-size:16px;line-height:1.6;color:#333;background-color:#fff;overflow:initial;box-sizing:border-box;word-wrap:break-word}html body>:first-child{margin-top:0}html body h1,html body h2,html body h3,html body h4,html body h5,html body h6{line-height:1.2;margin-top:1em;margin-bottom:16px;color:#000}html body h1{font-size:2.25em;font-weight:300;padding-bottom:.3em}html body h2{font-size:1.75em;font-weight:400;padding-bottom:.3em}html body h3{font-size:1.5em;font-weight:500}html body h4{font-size:1.25em;font-weight:600}html body h5{font-size:1.1em;font-weight:600}html body h6{font-size:1em;font-weight:600}html body h1,html body h2,html body h3,html body h4,html body h5{font-weight:600}html body h5{font-size:1em}html body h6{color:#5c5c5c}html body strong{color:#000}html body del{color:#5c5c5c}html body a:not([href]){color:inherit;text-decoration:none}html body a{color:#08c;text-decoration:none}html body a:hover{color:#00a3f5;text-decoration:none}html body img{max-width:100%}html body>p{margin-top:0;margin-bottom:16px;word-wrap:break-word}html body>ol,html body>ul{margin-bottom:16px}html body ol,html body ul{padding-left:2em}html body ol.no-list,html body ul.no-list{padding:0;list-style-type:none}html body ol ol,html body ol ul,html body ul ol,html body ul ul{margin-top:0;margin-bottom:0}html body li{margin-bottom:0}html body li.task-list-item{list-style:none}html body li>p{margin-top:0;margin-bottom:0}html body .task-list-item-checkbox{margin:0 .2em .25em -1.8em;vertical-align:middle}html body .task-list-item-checkbox:hover{cursor:pointer}html body blockquote{margin:16px 0;font-size:inherit;padding:0 15px;color:#5c5c5c;background-color:#f0f0f0;border-left:4px solid #d6d6d6}html body blockquote>:first-child{margin-top:0}html body blockquote>:last-child{margin-bottom:0}html body hr{height:4px;margin:32px 0;background-color:#d6d6d6;border:0 none}html body table{margin:10px 0 15px 0;border-collapse:collapse;border-spacing:0;display:block;width:100%;overflow:auto;word-break:normal;word-break:keep-all}html body table th{font-weight:700;color:#000}html body table td,html body table th{border:1px solid #d6d6d6;padding:6px 13px}html body dl{padding:0}html body dl dt{padding:0;margin-top:16px;font-size:1em;font-style:italic;font-weight:700}html body dl dd{padding:0 16px;margin-bottom:16px}html body code{font-family:Menlo,Monaco,Consolas,'Courier New',monospace;font-size:.85em;color:#000;background-color:#f0f0f0;border-radius:3px;padding:.2em 0}html body code::after,html body code::before{letter-spacing:-.2em;content:'\00a0'}html body pre>code{padding:0;margin:0;word-break:normal;white-space:pre;background:0 0;border:0}html body .highlight{margin-bottom:16px}html body .highlight pre,html body pre{padding:1em;overflow:auto;line-height:1.45;border:#d6d6d6;border-radius:3px}html body .highlight pre{margin-bottom:0;word-break:normal}html body pre code,html body pre tt{display:inline;max-width:initial;padding:0;margin:0;overflow:initial;line-height:inherit;word-wrap:normal;background-color:transparent;border:0}html body pre code:after,html body pre code:before,html body pre tt:after,html body pre tt:before{content:normal}html body blockquote,html body dl,html body ol,html body p,html body pre,html body ul{margin-top:0;margin-bottom:16px}html body kbd{color:#000;border:1px solid #d6d6d6;border-bottom:2px solid #c7c7c7;padding:2px 4px;background-color:#f0f0f0;border-radius:3px}@media print{html body{background-color:#fff}html body h1,html body h2,html body h3,html body h4,html body h5,html body h6{color:#000;page-break-after:avoid}html body blockquote{color:#5c5c5c}html body pre{page-break-inside:avoid}html body table{display:table}html body img{display:block;max-width:100%;max-height:100%}html body code,html body pre{word-wrap:break-word;white-space:pre}}.markdown-preview{width:100%;height:100%;box-sizing:border-box}.markdown-preview ul{list-style:disc}.markdown-preview ul ul{list-style:circle}.markdown-preview ul ul ul{list-style:square}.markdown-preview ol{list-style:decimal}.markdown-preview ol ol,.markdown-preview ul ol{list-style-type:lower-roman}.markdown-preview ol ol ol,.markdown-preview ol ul ol,.markdown-preview ul ol ol,.markdown-preview ul ul ol{list-style-type:lower-alpha}.markdown-preview .newpage,.markdown-preview .pagebreak{page-break-before:always}.markdown-preview pre.line-numbers{position:relative;padding-left:3.8em;counter-reset:linenumber}.markdown-preview pre.line-numbers>code{position:relative}.markdown-preview pre.line-numbers .line-numbers-rows{position:absolute;pointer-events:none;top:1em;font-size:100%;left:0;width:3em;letter-spacing:-1px;border-right:1px solid #999;-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none}.markdown-preview pre.line-numbers .line-numbers-rows>span{pointer-events:none;display:block;counter-increment:linenumber}.markdown-preview pre.line-numbers .line-numbers-rows>span:before{content:counter(linenumber);color:#999;display:block;padding-right:.8em;text-align:right}.markdown-preview .mathjax-exps .MathJax_Display{text-align:center!important}.markdown-preview:not([data-for=preview]) .code-chunk .code-chunk-btn-group{display:none}.markdown-preview:not([data-for=preview]) .code-chunk .status{display:none}.markdown-preview:not([data-for=preview]) .code-chunk .output-div{margin-bottom:16px}.markdown-preview .md-toc{padding:0}.markdown-preview .md-toc .md-toc-link-wrapper .md-toc-link{display:inline;padding:.25rem 0}.markdown-preview .md-toc .md-toc-link-wrapper .md-toc-link div,.markdown-preview .md-toc .md-toc-link-wrapper .md-toc-link p{display:inline}.markdown-preview .md-toc .md-toc-link-wrapper.highlighted .md-toc-link{font-weight:800}.scrollbar-style::-webkit-scrollbar{width:8px}.scrollbar-style::-webkit-scrollbar-track{border-radius:10px;background-color:transparent}.scrollbar-style::-webkit-scrollbar-thumb{border-radius:5px;background-color:rgba(150,150,150,.66);border:4px solid rgba(150,150,150,.66);background-clip:content-box}html body[for=html-export]:not([data-presentation-mode]){position:relative;width:100%;height:100%;top:0;left:0;margin:0;padding:0;overflow:auto}html body[for=html-export]:not([data-presentation-mode]) .markdown-preview{position:relative;top:0;min-height:100vh}@media screen and (min-width:914px){html body[for=html-export]:not([data-presentation-mode]) .markdown-preview{padding:2em calc(50% - 457px + 2em)}}@media screen and (max-width:914px){html body[for=html-export]:not([data-presentation-mode]) .markdown-preview{padding:2em}}@media screen and (max-width:450px){html body[for=html-export]:not([data-presentation-mode]) .markdown-preview{font-size:14px!important;padding:1em}}@media print{html body[for=html-export]:not([data-presentation-mode]) #sidebar-toc-btn{display:none}}html body[for=html-export]:not([data-presentation-mode]) #sidebar-toc-btn{position:fixed;bottom:8px;left:8px;font-size:28px;cursor:pointer;color:inherit;z-index:99;width:32px;text-align:center;opacity:.4}html body[for=html-export]:not([data-presentation-mode])[html-show-sidebar-toc] #sidebar-toc-btn{opacity:1}html body[for=html-export]:not([data-presentation-mode])[html-show-sidebar-toc] .md-sidebar-toc{position:fixed;top:0;left:0;width:300px;height:100%;padding:32px 0 48px 0;font-size:14px;box-shadow:0 0 4px rgba(150,150,150,.33);box-sizing:border-box;overflow:auto;background-color:inherit}html body[for=html-export]:not([data-presentation-mode])[html-show-sidebar-toc] .md-sidebar-toc::-webkit-scrollbar{width:8px}html body[for=html-export]:not([data-presentation-mode])[html-show-sidebar-toc] .md-sidebar-toc::-webkit-scrollbar-track{border-radius:10px;background-color:transparent}html body[for=html-export]:not([data-presentation-mode])[html-show-sidebar-toc] .md-sidebar-toc::-webkit-scrollbar-thumb{border-radius:5px;background-color:rgba(150,150,150,.66);border:4px solid rgba(150,150,150,.66);background-clip:content-box}html body[for=html-export]:not([data-presentation-mode])[html-show-sidebar-toc] .md-sidebar-toc a{text-decoration:none}html body[for=html-export]:not([data-presentation-mode])[html-show-sidebar-toc] .md-sidebar-toc .md-toc{padding:0 16px}html body[for=html-export]:not([data-presentation-mode])[html-show-sidebar-toc] .md-sidebar-toc .md-toc .md-toc-link-wrapper .md-toc-link{display:inline;padding:.25rem 0}html body[for=html-export]:not([data-presentation-mode])[html-show-sidebar-toc] .md-sidebar-toc .md-toc .md-toc-link-wrapper .md-toc-link div,html body[for=html-export]:not([data-presentation-mode])[html-show-sidebar-toc] .md-sidebar-toc .md-toc .md-toc-link-wrapper .md-toc-link p{display:inline}html body[for=html-export]:not([data-presentation-mode])[html-show-sidebar-toc] .md-sidebar-toc .md-toc .md-toc-link-wrapper.highlighted .md-toc-link{font-weight:800}html body[for=html-export]:not([data-presentation-mode])[html-show-sidebar-toc] .markdown-preview{left:300px;width:calc(100% - 300px);padding:2em calc(50% - 457px - 300px / 2);margin:0;box-sizing:border-box}@media screen and (max-width:1274px){html body[for=html-export]:not([data-presentation-mode])[html-show-sidebar-toc] .markdown-preview{padding:2em}}@media screen and (max-width:450px){html body[for=html-export]:not([data-presentation-mode])[html-show-sidebar-toc] .markdown-preview{width:100%}}html body[for=html-export]:not([data-presentation-mode]):not([html-show-sidebar-toc]) .markdown-preview{left:50%;transform:translateX(-50%)}html body[for=html-export]:not([data-presentation-mode]):not([html-show-sidebar-toc]) .md-sidebar-toc{display:none}
/* Please visit the URL below for more information: */
/*   https://shd101wyy.github.io/markdown-preview-enhanced/#/customize-css */
.markdown-preview.markdown-preview {
  font-family: "Noto Sans SC";
}

      </style>
      <!-- The content below will be included at the end of the <head> element. --><script type="text/javascript">
  document.addEventListener("DOMContentLoaded", function () {
    // your code here
  });
</script></head><body for="html-export">
    
    
      <div class="crossnote markdown-preview  ">
      
<h1 id="心内">心内 </h1>
<h2 id="1-高血压的定义和常见伴随危险因素">1. 高血压的定义和常见伴随危险因素 </h2>
<p>定义: 以体循环动脉压升高为主要临床表现的心血管综合征</p>
<p>常见伴随危险因素:</p>
<ol>
<li>遗传因素</li>
<li>环境因素
<ol>
<li>饮食</li>
<li>精神应激</li>
<li>吸烟</li>
</ol>
</li>
<li>其他因素
<ol>
<li>体重</li>
<li>药物</li>
<li>睡眠呼吸暂停通气综合征</li>
</ol>
</li>
</ol>
<h2 id="2-高血压一线用药药物种类">2. 高血压一线用药药物种类 </h2>
<ol>
<li>利尿药:
<ol>
<li>噻嗪类</li>
<li>袢利尿药</li>
<li>保钾利尿药
<blockquote>
<p>氢氯噻嗪, 氨苯蝶啶, 阿米洛利</p>
</blockquote>
</li>
</ol>
</li>
<li><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>β</mi></mrow><annotation encoding="application/x-tex">\beta</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8889em;vertical-align:-0.1944em;"></span><span class="mord mathnormal" style="margin-right:0.05278em;">β</span></span></span></span>受体拮抗剂
<ol>
<li>选择性<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>β</mi><mn>1</mn></msub></mrow><annotation encoding="application/x-tex">\beta _1</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8889em;vertical-align:-0.1944em;"></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.05278em;">β</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.3011em;"><span style="top:-2.55em;margin-left:-0.0528em;margin-right:0.05em;"><span class="pstrut" style="height:2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight">1</span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height:0.15em;"><span></span></span></span></span></span></span></span></span></span>受体阻滞剂</li>
<li>非选择性<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>β</mi></mrow><annotation encoding="application/x-tex">\beta</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8889em;vertical-align:-0.1944em;"></span><span class="mord mathnormal" style="margin-right:0.05278em;">β</span></span></span></span>受体阻滞剂</li>
<li>兼有<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>α</mi></mrow><annotation encoding="application/x-tex">\alpha</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.4306em;"></span><span class="mord mathnormal" style="margin-right:0.0037em;">α</span></span></span></span>受体阻滞作用的<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>β</mi></mrow><annotation encoding="application/x-tex">\beta</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8889em;vertical-align:-0.1944em;"></span><span class="mord mathnormal" style="margin-right:0.05278em;">β</span></span></span></span>受体阻滞剂
<blockquote>
<p>普萘洛尔, 美托洛尔, 阿替洛尔, 倍他乐克</p>
</blockquote>
</li>
</ol>
</li>
<li>钙离子拮抗剂
<ol>
<li>二氢吡啶类</li>
<li>非二氢吡啶类
<blockquote>
<p>氨氯地平, 硝苯地平, 尼卡地平</p>
</blockquote>
</li>
</ol>
</li>
<li>血管紧张素Ⅱ受体拮抗剂<br>
&gt; 氯沙坦, 缬沙坦, 厄贝沙坦</li>
</ol>
<h2 id="3-心衰的定义-分期">3. 心衰的定义, 分期 </h2>
<p>定义: 各种心脏结构或功能性疾病导致心室充盈和(或)射血功能受损, 心排血量不能满足机体组织代谢需要, 以循环和(或)体循环淤血, 器官, 组织血液灌注不足为临床表现的一组综合征.</p>
<p>分期:</p>
<table>
<thead>
<tr>
<th>分期</th>
<th>阶段</th>
</tr>
</thead>
<tbody>
<tr>
<td>A期</td>
<td>前心衰阶段</td>
</tr>
<tr>
<td>B期</td>
<td>前临床心衰阶段</td>
</tr>
<tr>
<td>C期</td>
<td>临床心衰阶段</td>
</tr>
<tr>
<td>D期</td>
<td>难治性终末期心衰阶段</td>
</tr>
</tbody>
</table>
<h2 id="4-心衰药物治疗的种类">4. 心衰药物治疗的种类 </h2>
<ol>
<li>利尿药
<ol>
<li>袢利尿剂</li>
<li>噻嗪类利尿剂</li>
<li>保钾利尿剂</li>
<li>AVP受体拮抗剂</li>
</ol>
</li>
<li>RAAS抑制剂
<blockquote>
<p>ACEI, ARB, ARNI, 醛固酮受体拮抗剂, 肾素抑制剂</p>
</blockquote>
</li>
<li><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>β</mi></mrow><annotation encoding="application/x-tex">\beta</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8889em;vertical-align:-0.1944em;"></span><span class="mord mathnormal" style="margin-right:0.05278em;">β</span></span></span></span>受体拮抗剂</li>
<li>正性肌力药
<blockquote>
<p>洋地黄类药物, <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>β</mi></mrow><annotation encoding="application/x-tex">\beta</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.8889em;vertical-align:-0.1944em;"></span><span class="mord mathnormal" style="margin-right:0.05278em;">β</span></span></span></span>受体兴奋剂, 磷酸二酯酶抑制剂</p>
</blockquote>
</li>
<li>伊伐布雷定</li>
<li>扩血管药物</li>
</ol>
<h2 id="5-胸痛的鉴别诊断">5. 胸痛的鉴别诊断 </h2>
<p>肺栓塞, 主动脉夹层, 心绞痛, 肋间神经痛, 肺炎, 胃穿孔, 急性心包炎, 胃食管反流</p>
<h2 id="6-冠心病的分类">6. 冠心病的分类 </h2>
<ol>
<li>慢性冠脉疾病
<ol>
<li>稳定型心绞痛</li>
<li>缺血性心肌病</li>
<li>隐匿性冠心病</li>
</ol>
</li>
<li>急性冠脉综合征
<ol>
<li>不稳定型心绞痛</li>
<li>非ST段抬高型心肌梗死</li>
<li>ST段抬高型心肌梗死</li>
</ol>
</li>
</ol>
<h2 id="7-急性心梗的全球定义及具体标准">7. 急性心梗的全球定义及具体标准 </h2>
<p>全球定义: 由于心机缺血所导致的心肌细胞坏死</p>
<p>具体标准:</p>
<ol>
<li>症状
<ol>
<li>疼痛: 常发生于安静时, 程度较重, 持续时间较长, 可达数小时或更长, 休息和含用硝酸甘油片多不能缓解</li>
<li>全身症状: 有发热, 心动过速, 白蛋白计数增高和红细胞沉降率增快等</li>
<li>胃肠道症状: 疼痛剧烈时常伴有频繁的恶心, 呕吐和上腹胀痛</li>
<li>心律失常: 以室性心律时常最多</li>
<li>低血压和休克</li>
<li>心力衰竭</li>
</ol>
</li>
<li>体征
<ol>
<li>心脏体征: 心脏浊音界可轻度至中度增大, 心尖区第一心音减弱, 可出现第四心音奔马律</li>
<li>血压降低</li>
</ol>
</li>
<li>心电图: ST段抬高至弓背向上型; 宽而深的Q波; T波倒置</li>
<li>血清心肌坏死标志物升高</li>
</ol>
<h2 id="8-房颤的分类定义及治疗原则">8. 房颤的分类定义及治疗原则 </h2>
<p>分类定义:</p>
<ol>
<li>首诊房颤: 首次确诊(首次发作或首次发现)</li>
<li>阵发性房颤: 持续时间 <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>≤</mo></mrow><annotation encoding="application/x-tex">\leq</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.7719em;vertical-align:-0.136em;"></span><span class="mrel">≤</span></span></span></span> 7天(常 <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>≤</mo></mrow><annotation encoding="application/x-tex">\leq</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.7719em;vertical-align:-0.136em;"></span><span class="mrel">≤</span></span></span></span> 48小时), 能自行终止</li>
<li>持续性房颤: 持续时间 <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>&gt;</mo></mrow><annotation encoding="application/x-tex">&gt;</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.5782em;vertical-align:-0.0391em;"></span><span class="mrel">&gt;</span></span></span></span> 7天, 非自限性</li>
<li>长期持续性房颤: 持续时间 <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>≥</mo></mrow><annotation encoding="application/x-tex">\geq</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.7719em;vertical-align:-0.136em;"></span><span class="mrel">≥</span></span></span></span> 1年, 病人又转复愿望</li>
<li>永久性房颤: 持续时间 <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>&gt;</mo></mrow><annotation encoding="application/x-tex">&gt;</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.5782em;vertical-align:-0.0391em;"></span><span class="mrel">&gt;</span></span></span></span> 1年, 不能终止或终止后又复发</li>
</ol>
<p>治疗原则: 在治疗原发疾病和诱发因素基础上, 积极预防血栓栓塞, 转复并维持窦性心律及控制心室率</p>
<h2 id="9-非瓣膜并房颤血栓及出血风险评估及抗凝选择">9. 非瓣膜并房颤血栓及出血风险评估及抗凝选择 </h2>
<h3 id="91-出血风险评估-has-bled-评分">9.1. 出血风险评估 HAS-BLED 评分 </h3>
<table>
<thead>
<tr>
<th>临床特点</th>
<th>计分</th>
</tr>
</thead>
<tbody>
<tr>
<td>高血压 (H)</td>
<td>1</td>
</tr>
<tr>
<td>肝肾功能异常(各1分) (A)</td>
<td>1或2</td>
</tr>
<tr>
<td>脑卒中 (S)</td>
<td>1</td>
</tr>
<tr>
<td>INR值易波动 (L)</td>
<td>1</td>
</tr>
<tr>
<td>年龄 <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>&gt;</mo></mrow><annotation encoding="application/x-tex">&gt;</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.5782em;vertical-align:-0.0391em;"></span><span class="mrel">&gt;</span></span></span></span> 65岁 (E)</td>
<td>1</td>
</tr>
<tr>
<td>药物或酗酒 (各1分) (D)</td>
<td>1或2</td>
</tr>
</tbody>
</table>
<h3 id="92-血栓风险评估">9.2. 血栓风险评估 </h3>
<table>
<thead>
<tr>
<th>危险因素</th>
<th>CHA<sub>2</sub>DS<sub>2</sub>-VASc 评分</th>
</tr>
</thead>
<tbody>
<tr>
<td>充血性心衰/左心室功能障碍 (C)</td>
<td>1</td>
</tr>
<tr>
<td>高血压 (H)</td>
<td>1</td>
</tr>
<tr>
<td>年龄 <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>&gt;</mo></mrow><annotation encoding="application/x-tex">&gt;</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.5782em;vertical-align:-0.0391em;"></span><span class="mrel">&gt;</span></span></span></span> 75岁 (A)</td>
<td>2</td>
</tr>
<tr>
<td>糖尿病 (D)</td>
<td>1</td>
</tr>
<tr>
<td>脑卒中/TIA/血栓栓塞病史 (S)</td>
<td>2</td>
</tr>
<tr>
<td>血管疾病 (V)</td>
<td>1</td>
</tr>
<tr>
<td>年龄 65~74岁 (A)</td>
<td>1</td>
</tr>
<tr>
<td>性别 (女性) (S)</td>
<td>1</td>
</tr>
</tbody>
</table>
<h3 id="93-抗凝选择">9.3. 抗凝选择 </h3>
<p>目前主要选择达比加群, 阿哌沙班, 利伐沙班等. 特点为不需要常规凝血指标监测, 较少受食物或药物影响.</p>

      </div>
      
      
    
    
    
    
    
    
  
    </body></html>